Test Description
Extractables & Leachables
Sample Type: 3 Extracts
Method: ISO 10993-18
Direct Contact Method
Sample Type: Liquid/Semi-Solid or 1 Extract
Method: USP <87>
Nuetral Red Uptake (NRU) - Elution or Direct Contact
Sample Type: Liquid/Semi-Solid or 1 Extract
Method: ISO 10993-5
XTT Dye Method - Elution or Direct Contact
Sample Type: Liquid/Semi-Solid or 1 Extract
Method: ISO 10993-5
MTT - Elution or Direct Contact
Sample Type: Liquid/Semi-Solid or 1 Extract
Method: ISO 10993-5
MEM Elution Method
Sample Type: Liquid/Semi-Solid or 1 Extract
Method: ISO 10993-5; USP <87>
Maximization Test (GPMT)
Sample Type: 2 Extracts
Method: ISO 10993-10
MHLW MaximizationTest (GPMT)
Sample Type: Exaggerated Extraction
Method: MHLW
Murine Local Lymph Node Assay (LLNA)
Sample Type: 2 Extracts
Method: ISO 10993-10
Buehler Method
Sample Type: Fabric
Method: ISO 10993-10
Preliminary Test
Sample Type: Extraction in Acetone and Ethanol
Method: MHLW
Main Test Extraction with Method 1 or 2
Sample Type: Extraction in Acetone or Ethanol
Method: MHLW
Intracutaneous Reactivity
Sample Type: 2 Extracts
Method: ISO 10993-10
Primary Eye Irritation (72 hrs.)
Sample Type: 2 Extracts
Method: ISO 10993-10
Intracutaneous Reactivity
Sample Type: 4 Extracts
Method: USP <88>Primary Skin Irritation (72 hrs.)
Sample Type: 2 Extracts
Method: ISO 10993-10
Buccal Mucosa w/ Histo. (48 hrs.)
Sample Type: 2 Extracts
Method: ISO 10993-10
Acute Systemic Toxicity
Sample Type: 2 Extracts
Method: ISO 10993-11
Subacute Systemic Toxicity
Sample Type: Liquid/Semi-Solid or Extract
Method: ISO 10993-11
Subchronic Systemic Toxicity
Sample Type: Liquid/Semi-Solid or Extract
Method: ISO 10993-11
Chronic Systemic Toxicity
Sample Type: Liquid/Semi-Solid or Extract
Method: ISO 10993-11
Material Mediated Pyrogen
Sample Type: 1 Extract (Polar Only)
Method: USP <151>
Ames Mutagenicity Test (1 concentration of each extract)
Sample Type: 2 Extracts
Method: ISO 10993-3 & 33; OECD 471
Ames Mutagenicity Test (5 concentration of each extract)
Sample Type: 2 Extracts
Method: ISO 10993-3 & 33; OECD 471
MLA Lymphoma Forward Mutation Assay
Sample Type: 2 Extracts
Method: ISO 10993-3; OCED 490
Chromosomal Aberration Assay
Sample Type: 2 Extracts
Method: ISO 10993-3; OECD 473
In Vivo - Peripheral Blood Micronucleus Test (Limit Test)
Sample Type: 2 Extracts
Method: ISO 10993-3 & 33; OECD 474
ASTM Hemolysis (Static Design)
Sample Type: Blood Contact
Method: Direct Contact - ASTM F756
ASTM Hemolysis (Static Design)
Sample Type: Blood Contact
Method: Extract Method - ASTM F756
Hematology (Static Design); Platelet and Leukocyte
Sample Type: Blood Contact
Method: ISO 10993-4
Partial Thromboplastin Time (PTT)
Sample Type: Blood Contact
Method: ISO 10993-4
Complement Activation (SC5b-9)
Sample Type: Blood Contact
Method: ISO 10993-4
Thrombogenicity
Sample Type: Blood Contact
Method: ISO 10993-4
Class VI (Implantation, Acute Sys. Tox, Intracut. Reac.)
Sample Type: Multiple Extracts
Method: USP <88>
Intramuscular, 5 Days of Implantation
Sample Type: Implant
Method: USP <88>
Subcutaneous, 7 Days of Implantation
Sample Type: Implant
Method: USP <88>
Subcutaneous, Muscle or Bone (4 week) w/ Histo
Sample Type: Implant
Method: 10993-6
Subcutaneous, Muscle or Bone (13 week) w/ Histo
Sample Type: Implant
Method: 10993-6
Subcutaneous, Muscle or Bone (26 week) w/ Histo
Sample Type: Implant
Method: 10993-6
Subcutaneous, Muscle or Bone (52 week) w/ Histo
Sample Type: Implant
Method: 10993-6